Embelin prevents amyloid-beta accumulation via modulation of SOD1 in a Streptozotocin-induced AD-like condition: An evidence from in vitro investigation

Embelin is a neuroprotective compound with therapeutic benefit against experimental Alzheimer's disease (AD)-like condition. In the quest of untangling the underlying mechanism behind the neuroprotective effect of Embelin in AD, an in-vitro study of Embelin against neuronal damage induced by St...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhuvanendran, Saatheeyavaane, Paudel, Yam Nath, Kumari, Yatinesh, Othman, Iekhsan, Shaikh, Mohd. Farooq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743048/
https://www.ncbi.nlm.nih.gov/pubmed/36518345
http://dx.doi.org/10.1016/j.crneur.2022.100032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743048/
https://www.ncbi.nlm.nih.gov/pubmed/36518345
http://dx.doi.org/10.1016/j.crneur.2022.100032

Ejemplares similares